Their discontinuance of the LCI versions of ER and IR may be a clue as to their cancellation remorse. Hopefully are fearless leader will have something to say about that on the conference call.
Regarding Sabril, the REMS recent approval bodes well for a near term launch.
News 
Market Data 
Discover 
